Invention Grant
- Patent Title: Benzodiazepines as bromodomain inhibitors
-
Application No.: US15749950Application Date: 2016-08-04
-
Publication No.: US10167292B2Publication Date: 2019-01-01
- Inventor: Chris Burns , Jean-Marc Garnier , Phillip Patrick Sharp , John Feutrill , Anthony Cuzzupe
- Applicant: Catalyst Therapeutics Pty Ltd
- Applicant Address: AU Victoria
- Assignee: Catalyst Therapeutics Pty Ltd.
- Current Assignee: Catalyst Therapeutics Pty Ltd.
- Current Assignee Address: AU Victoria
- Agency: Cooley LLP
- Agent Ivor R. Elrifi; Matthew Pavao
- Priority: AU2015903111 20150804
- International Application: PCT/AU2016/050703 WO 20160804
- International Announcement: WO2017/020086 WO 20170209
- Main IPC: C07D487/04
- IPC: C07D487/04
Abstract:
The present invention provides novel benzodiazepine derivatives of Formula I or pharmaceutically acceptable derivatives, polymorphs, salts or prodrugs thereof. Said compounds have potential as bromodomain (BRD) inhibitors.
Public/Granted literature
- US20180230153A1 Benzodiazepines as bromodomain inhibitors Public/Granted day:2018-08-16
Information query
